Additional packages of clonazepam, a prescription medication used to treat seizures and anxiety, mislabeled with the incorrect strength have been added to a voluntary recall, according to the U.S. Food and Drug Administration.
Endo, Inc., the manufacturer of clonazepam, expanded the recall, first announced in July, to 16 lots of the medication, according to a recall notice shared by the FDA on Nov. 19.
The recalled product, clonazepam Orally Disintegrating Tablets, comes in cartons, “containing 60 tablets packed into 10 blister strips each containing 6 tablets,” according to Endo.
The affected cartons are printed with the incorrect strength and National Drug Code, while the blister strips and tablets inside reflect the correct strength, according to the company, which blamed the error on a “third-party packager.”
